National Health Investors, Inc. (NHI)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 14/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 4.33% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- National Health Investors (NHI) Heads To BofA Conference On An Undervalued Senior Housing Narrative
- BXP vs. NHI: Which Stock Is the Better Value Option?
- NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline
- CUZ vs. NHI: Which Stock Should Value Investors Buy Now?
- PEB or NHI: Which Is the Better Value Stock Right Now?
- National Health Investors Inc (NHI) (Q2 2026) Earnings Call Highlights: Strategic Pivot to SHOP ...
- National Health Investors Q2 Earnings Call Highlights
- National Health Investors (NHI) Q2 FFO Lag Estimates
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Financial incentives and health coaching to improve glycemic outcomes among young adults with type 1 diabetes: A factorial randomized trial (SweetGoals). — Diabetes Res Clin Pract 2026 Sep PMID 42580596
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for National Health Investors, Inc..
Full NHI Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.